How big is the Global Metabolomics Market?

The Global Metabolomics Market size is expected to reach USD 2.26 billion in 2024 and grow at a CAGR of 11.02% to reach USD 3.82 billion by 2029. Read More

What is the current Global Metabolomics Market size?

In 2024, the Global Metabolomics Market size is expected to reach USD 2.26 billion. Read More

Who are the key players in Global Metabolomics Market?

Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Agilent Technologies Inc., Bruker and Danaher Corporation (SCIEX) are the major companies operating in the Global Metabolomics Market. Read More

Which is the fastest growing region in Global Metabolomics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Metabolomics Market?

In 2024, the North America accounts for the largest market share in Global Metabolomics Market. Read More

What years does this Global Metabolomics Market cover, and what was the market size in 2023?

In 2023, the Global Metabolomics Market size was estimated at USD 2.04 billion. The report covers the Global Metabolomics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Metabolomics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Metabolomics Market - Size & Industry Analysis

Metabolomics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Metabolomics Market Insights & Share. The market is Segmented by Metabolite Analysis (Analytical Techniques, Detection Techniques, and Bioinformatics Tools and Databases), Application (Biomarker and Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the market sizes and forecasts in terms of value (USD million) for the above segments.

Metabolomics Industry Overview

The metabolomics market is moderately competitive and consists of several major players. The major global companies, such as Thermofisher, Bruker Corporation, and Agilent Technologies, are increasingly collaborating with educational societies and research communities, funding them for more research and providing combination, separation, and detection technique licenses. With the specific requirements of metabolite research, HPLC and UPLC are increasingly preferred over other techniques for their versatile separation methods. Several pharmaceutical companies prefer research institutes to characterize toxicological studies and develop new drugs against infectious diseases. Technical advancements and combinations with MS and NMR are being rapidly adopted globally.